The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Updated recommendation by Touchstone Innovations

18 Oct 2017 09:38

RNS Number : 9375T
Touchstone Innovations PLC
18 October 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

 

18 October 2017

 

Touchstone Innovations plc

 

Updated recommendation by Touchstone Innovations plc regarding IP Group plc offer (the "Offer")

Further to the announcements by IP Group plc ("IP Group"), the Board of Touchstone Innovations plc ("Touchstone" or the "Company") notes that the CMA clearance condition to the Offer has been fulfilled and that the Offer has been declared wholly unconditional as of this morning.

The Board of Touchstone also notes that IP Group has received valid acceptances in respect of 155,859,312 Touchstone shares, representing approximately 96.6844 per cent of the existing issued share capital of Touchstone, and IP Group's stated intention to commence the procedure pursuant to Chapter 3 of Part 28 of the Companies Act 2006 to compulsorily acquire the remaining Touchstone shares in respect of which the Offer is not accepted on the same terms as the Offer.

Given that the Offer is now wholly unconditional, the Board of Touchstone recommends that Touchstone shareholders who have not yet accepted the Offer now do so promptly.

Those Touchstone shareholders who accept the Offer will receive their new shares in IP Group as consideration for their Touchstone shares at an earlier date than they would as part of the compulsory acquisition procedure referred to above.

The procedure for acceptance of the IP Group Offer is set out in the IP Group offer document dated 18 July 2017, the "Update on Offer for Touchstone Innovations plc" announcement dated 18 September 2017 as well as the "Offer update - Wholly unconditional" announcement dated 18 October 2017.

IP Group has announced that the Offer will remain open until further notice and that not less than 14 calendar days' notice will be given in respect of the closure of the Offer.

The directors of Touchstone who own shares in Touchstone in their personal capacity have decided to accept the Offer in respect of their own beneficial holdings.

If you are a Touchstone shareholder and in any doubt as to the action you should take, you are recommended to seek your own financial advice immediately from your stockbroker, bank manager, solicitor, accountant, fund manager or other appropriate independent financial adviser authorised under the Financial Services and Markets Act 2000, as amended if you are resident in the United Kingdom or, if not, from another appropriately authorised independent financial adviser.

 

*****

 

Enquiries:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings

J.P. Morgan Cazenove (Financial Adviser and Corporate Broker to Touchstone Innovations plc)

020 7742 4000

Michael Wentworth-Stanley/ James Robinson/ Alec Pratt

RBC Capital Markets

(Joint Corporate Broker to Touchstone Innovations plc)

020 7653 4000

Marcus Jackson

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

Further Information

 

J.P. Morgan Limited, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised and regulated in the United Kingdom by the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Touchstone Innovations plc and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Touchstone Innovations plc for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, or for providing advice in relation to any matter referred to herein.

RBC Capital Markets is the business name used by RBC Europe Limited, which is authorised in the United Kingdom by the Prudential Regulation Authority ("PRA") and regulated by the Financial Conduct Authority and the PRA and is a subsidiary of the Royal Bank of Canada. RBC is acting as Corporate Broker to the Company.

Responsibility

The directors of Touchstone accept responsibility for the information contained in this announcement (including expressions of belief) and, to the best of the knowledge and belief of the Touchstone directors (having taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

Additional Information

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.touchstoneinnovations.com by no later than 12 noon (London time) on the business day following this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Ends

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPVVLBFDBFXFBE
Date   Source Headline
24th Apr 200912:06 pmPRNHolding(s) in Company
16th Apr 20097:00 amPRNNotice of Half Year Results
8th Apr 20096:21 pmPRNCompletion of Investment
2nd Apr 200910:45 amPRNClarification re. Investment in Portfolio Company
2nd Apr 20097:00 amPRNInvestment in Portfolio Company
24th Mar 20097:00 amRNSPortfolio Company Nexeon Announces New CEO
20th Feb 20097:00 amRNSSeed Funding in Three New Companies
11th Feb 20097:00 amRNSInvestment in Nexeon Ltd
4th Feb 20096:24 pmPRNHolding(s) in Company
29th Jan 20097:00 amRNSNew Portfolio Company Formation
23rd Jan 200910:49 amRNSNovacem wins rushlight award
20th Jan 20097:00 amRNSHolding(s) in Company
20th Jan 20097:00 amPRNTransfer of shares to Imperial College
7th Jan 20094:18 pmPRNHolding in Company
18th Dec 200812:27 pmPRNPortfolio Company Trade Sale
15th Dec 20083:20 pmPRNResult of AGM
17th Nov 20081:20 pmPRNNotice of AGM
14th Oct 20087:00 amPRNFinal Results
17th Sep 20089:30 amRNSSenior Appointments
11th Sep 20081:27 pmPRNPortfolio Company's Clinical Study Results
15th Aug 20087:00 amRNSPortfolio Companies Receive I
14th Aug 20084:35 pmPRNFormation of subsidiary authorised by FSA
10th Jul 20087:00 amPRNAppointment of non-executive director
2nd Jul 20087:00 amRNSAnnouncement re Recyclatech
23rd Jun 20087:00 amPRNInvestment in OSspray Limited
30th May 20089:00 amRNSInvestment in Evince
30th Apr 20087:00 amPRNHalf-yearly Report
22nd Apr 20083:28 pmPRNNotice of Results
14th Apr 20087:01 amRNSInvestment in Spiral Gateway
13th Mar 200811:53 amRNSTherapeutics portfolio update
21st Feb 20082:35 pmPRNDirectorate Change
20th Feb 200810:51 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amPRNInvestment in Circassia
21st Jan 200812:26 pmRNSi2india agreement with CCI
14th Jan 200810:30 amRNSBiosciences Deals
12th Dec 20073:04 pmRNSResult of AGM
11th Dec 200711:18 amRNSProof of Concept Programme
29th Nov 20074:00 pmRNSHolding(s) in Company
29th Nov 20073:59 pmRNSHolding(s) in Company
27th Nov 20072:04 pmRNSHolding(s) in Company
22nd Nov 20072:53 pmRNSTotal Voting Rights
22nd Nov 20078:00 amRNSFunding raised for i2india
22nd Nov 20078:00 amRNSAdmission of Shares on AIM
21st Nov 200712:11 pmRNSResult of EGM
14th Nov 200711:25 amRNSHolding(s) in Company
9th Nov 20073:56 pmPRNAnnual Report and Accounts
9th Nov 20079:00 amRNSEPS Licensing Deal
8th Nov 200711:55 amRNSHolding(s) in Company
30th Oct 20072:19 pmPRNCirc re GBP30m Placing
26th Oct 20071:35 pmPRNGBP30m placing successful

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.